These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

994 related items for PubMed ID: 23416216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [Abstract] [Full Text] [Related]

  • 3. Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence.
    Liu X, Feng M, Zhang Y, Dai C, Sun B, Bao X, Deng K, Yao Y, Wang R.
    World Neurosurg; 2018 May; 113():e213-e221. PubMed ID: 29432944
    [Abstract] [Full Text] [Related]

  • 4. PTTG and Ki-67 expression in pituitary adenomas.
    Wierzbicka-Tutka I, Sokołowski G, Bałdys-Waligórska A, Adamek D, Radwańska E, Gołkowski F.
    Przegl Lek; 2016 May; 73(2):53-8. PubMed ID: 27197423
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes.
    Salehi F, Kovacs K, Scheithauer BW, Cantelmi D, Horvath E, Lloyd RV, Cusimano M.
    Int J Surg Pathol; 2010 Feb; 18(1):5-13. PubMed ID: 20106827
    [Abstract] [Full Text] [Related]

  • 6. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
    McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA, Gittoes NJ.
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
    [Abstract] [Full Text] [Related]

  • 7. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [Abstract] [Full Text] [Related]

  • 8. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A, Morandi L, Leonardi E, Farnedi A, Marucci G, Sisto A, Frank G, Faustini-Fustini M, Zoli M, Mazzatenta D, Agati R, Foschini MP.
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J, Sáez L, Lemp M, Liberman C, Michelsen H, Araya AV.
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [Abstract] [Full Text] [Related]

  • 10. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
    Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
    [Abstract] [Full Text] [Related]

  • 11. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W, Lüdecke B, Lüdecke DK.
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [Abstract] [Full Text] [Related]

  • 12. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S, Doglietto F, Trapasso B, Iacovazzo D, Giampietro A, Di Nardo F, de Waure C, Lauriola L, Mangiola A, Anile C, Maira G, De Marinis L, Bianchi A.
    Neuroendocrinology; 2015 Feb; 101(2):143-50. PubMed ID: 25633744
    [Abstract] [Full Text] [Related]

  • 13. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L, Liu YS, Wang LS, Yin HG, Hou QT, Liu ZX, Chen LH, Ling F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
    [Abstract] [Full Text] [Related]

  • 14. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A, Asa SL, Fadda G, Scannone D, Chiloiro S, De Marinis L, Lauretti L, Ranelletti FO, Lauriola L.
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [Abstract] [Full Text] [Related]

  • 15. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
    Šteňo A, Bocko J, Rychlý B, Chorváth M, Celec P, Fabian M, Belan V, Šteňo J.
    Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
    [Abstract] [Full Text] [Related]

  • 16. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Vergès B, Chabre O, Calender A, Groupe d'études des Tumeurs Endocrines.
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F, Hancke K, Petrick M, Göbel H, Honegger J, Reincke M.
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.
    Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Veltri F, Angelini F, Lauriola L, Vellone V, Doglietto F, Ambrosio MR, Maira G, Giustina A, degli Uberti EC, Pontecorvi A, De Marinis L.
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2746-50. PubMed ID: 18460561
    [Abstract] [Full Text] [Related]

  • 19. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P, Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Murakami K, Zheng S, Iwase H.
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [Abstract] [Full Text] [Related]

  • 20. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
    Boelaert K, McCabe CJ, Tannahill LA, Gittoes NJ, Holder RL, Watkinson JC, Bradwell AR, Sheppard MC, Franklyn JA.
    J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.